Study Identifies Novel Epigenetic Changes in Pediatric Brain Cancer

Dec 7, 2022

Investigators have identified previously unknown sets of epigenetic changes in pediatric brain tumors, which could serve as novel therapeutic targets and provide alternative treatment options for patients, according to a Northwestern Medicine study published in Nature Communications.

Comments

Treating a deadly childhood cancer with a sideways approach

Childhood Cancer Survivors Have Higher Risk of Chronic Conditions, Early Death

A new CAR-T-cell therapy tricks cancer cells with a decoy to increase treatment efficiency in B-cell Acute Lymphoblastic Leukaemia

Experimental treatment borrowed from blood cancer shows promise for pediatric brain tumors

Classifying childhood brain cancers by immune response may improve diagnostics and treatments

Is Less More? Rethinking Salvage Therapy in Pediatric Hodgkin Lymphoma

Newborns with heart defects may face a higher risk of developing childhood cancer

New therapeutic approach shows promise for pediatric high-grade gliomas

Space-age lessons could protect childhood cancer survivors’ bone health

Suicidal ideation significantly higher among childhood cancer survivors

Recent Posts